• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV251T
Device Problems Obstruction of Flow (2423); Free or Unrestricted Flow (2945)
Patient Problems Failure of Implant (1924); Hydrocephalus (3272)
Event Date 02/12/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient information: height cm: 160.When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "4 year 11 month po overdrain of the valve." additional patient information has been requested.When additional information is received a follow up report will be submitted.All medwatch submissions related to this patient are: 3004721439-2019-00056, 3004721439-2019-00057 (this report).
 
Manufacturer Narrative
Manufacturing site evaluation: the shunt system was manufactured by a qualified employee; deviations during assembly did not occur.All parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Investigation - the shunt system was received submersed.No significant deformations or damage of the valve were detected during the visual inspection.Permeability test- the test has shown that the valve is permeable.The flow rate was slower than expected.Adjustment test - this is a fixed pressure valve.An adjustment test was not applicable.Braking force and brake function test - this is a fixed pressure valve.A braking force and brake function test is not applicable.Computer controlled test - to investigate the claim of over-drainage, the opening pressure is measured using a testing apparatus which simulates a cerebrospinal fluid (csf) flow.The valve is tested in the vertical position and was tested twice.The first results showed that the valve was not operating within the acceptable tolerance.Upon a seond test, the opening pressure value moved just within tolerance.This was likely due to a clearing out of the valve due to the nature of the test.Results - after the tests, we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).Based on our investigation, we confirm that the valve was operating in an over-drainage state, likely due to the deposits observed inside the valve.As described in our literature, the problem encountered is one of the known, inevitable risks of hydrocephalus therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHUNTASSISTANT 20
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam, 14469
GM  14469
MDR Report Key8384020
MDR Text Key137662079
Report Number3004721439-2019-00057
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 06/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2016
Device Model NumberFV251T
Device Catalogue NumberFV251T
Device Lot Number4503261549
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/14/2019
Distributor Facility Aware Date03/13/2019
Device Age8 YR
Date Manufacturer Received03/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age23 YR
Patient Weight30
-
-